Home
VTRS
VTRS News

Latest Viatris Inc. (VTRS) News on June 1, 2025

Viatris Announces Launch of First Clozapine Orally Disintegrating Tablet (ODT) in Canada

CNW Group

5 days ago

Viatris Announces Launch of First Clozapine Orally Disintegrating Tablet (ODT) in Canada

3 Stocks Under $10 Skating on Thin Ice

StockStory

10 days ago

3 Stocks Under $10 Skating on Thin Ice

Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers

StockStory

10 days ago

Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers

Viatris to Participate in Upcoming Investor Conferences

PR Newswire

10 days ago

Viatris to Participate in Upcoming Investor Conferences

MT Newswires

10 days ago

Piper Sandler Adjusts Price Target on Viatris to $9 From $10, Maintains Neutral Rating

Argus Research

17 days ago

Daily – Vickers Top Buyers & Sellers for 05/15/2025

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

StockStory

19 days ago

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Theravance's Q1 Loss Wider Than Expected, Revenues Rise Y/Y

Zacks

23 days ago

Theravance's Q1 Loss Wider Than Expected, Revenues Rise Y/Y

GuruFocus.com

23 days ago

Viatris Inc (VTRS) Q1 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing on ...

Thomson Reuters StreetEvents

23 days ago

Q1 2025 Viatris Inc Earnings Call

Morningstar Research

24 days ago

Analyst Report: Viatris Inc.

Viatris Q1 Earnings and Revenues Beat Estimates, Stock Gains

Zacks

24 days ago

Viatris Q1 Earnings and Revenues Beat Estimates, Stock Gains

Viatris (NASDAQ:VTRS) Reports Sales Below Analyst Estimates In Q1 Earnings, But Stock Soars 8%

StockStory

24 days ago

Viatris (NASDAQ:VTRS) Reports Sales Below Analyst Estimates In Q1 Earnings, But Stock Soars 8%

Viatris (VTRS) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks

24 days ago

Viatris (VTRS) Reports Q1 Earnings: What Key Metrics Have to Say

Viatris (VTRS) Beats Q1 Earnings and Revenue Estimates

Zacks

24 days ago

Viatris (VTRS) Beats Q1 Earnings and Revenue Estimates

Viatris’ new form of old pain drug scores in large trials

BioPharma Dive

24 days ago

Viatris’ new form of old pain drug scores in large trials

MT Newswires

24 days ago

Viatris' Q1 Adjusted Earnings, Revenue Decline; 2025 Adjusted EPS Outlook Raised

Associated Press Finance

24 days ago

Viatris: Q1 Earnings Snapshot

Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook

PR Newswire

24 days ago

Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook

Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential

PR Newswire

24 days ago

Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential

Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain

PR Newswire

24 days ago

Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain

Viatris Announces Quarterly Dividend

PR Newswire

25 days ago

Viatris Announces Quarterly Dividend

Viatris Earnings: What To Look For From VTRS

StockStory

25 days ago

Viatris Earnings: What To Look For From VTRS

MT Newswires

a month ago

Sector Update: Health Care Stocks Fall Late Afternoon

MT Newswires

a month ago

Heron Settles Patent Litigation With Mylan Over Cinvanti, Aponvie; Shares Rise

Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors

PR Newswire

a month ago

Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors

Unveiling Viatris (VTRS) Q1 Outlook: Wall Street Estimates for Key Metrics

Zacks

a month ago

Unveiling Viatris (VTRS) Q1 Outlook: Wall Street Estimates for Key Metrics

2 S&P 500 Stocks Worth Investigating and 1 to Avoid

StockStory

a month ago

2 S&P 500 Stocks Worth Investigating and 1 to Avoid

Viatris Q1 Earnings Release: What's in Store for the Stock?

Zacks

a month ago

Viatris Q1 Earnings Release: What's in Store for the Stock?

Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for

Zacks

a month ago

Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for

Viatris Inc. (VTRS): Among the Worst Performing Stocks in S&P 500 So Far in 2025

Insider Monkey

a month ago

Viatris Inc. (VTRS): Among the Worst Performing Stocks in S&P 500 So Far in 2025

Viatris Inc. (VTRS): One of the Cheap Quarterly Dividend Stocks to Buy Now

Insider Monkey

a month ago

Viatris Inc. (VTRS): One of the Cheap Quarterly Dividend Stocks to Buy Now

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

StockStory

a month ago

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

Viatris Inc. (VTRS): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

Insider Monkey

a month ago

Viatris Inc. (VTRS): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

Viatris to Present at the BofA Securities 2025 Healthcare Conference

PR Newswire

a month ago

Viatris to Present at the BofA Securities 2025 Healthcare Conference

3 Reasons VTRS is Risky and 1 Stock to Buy Instead

StockStory

a month ago

3 Reasons VTRS is Risky and 1 Stock to Buy Instead

Is Viatris Inc. (NASDAQ:VTRS) the Best Cheap Stock to Buy Under $10?

Insider Monkey

a month ago

Is Viatris Inc. (NASDAQ:VTRS) the Best Cheap Stock to Buy Under $10?

MT Newswires

a month ago

BofA Trims Price Target on Viatris to $8 From $10

MT Newswires

a month ago

Sector Update: Health Care Stocks Fall Pre-Bell Monday

MT Newswires

a month ago

Viatris Applies for Japan Approval of Effexor to Treat Generalized Anxiety Disorder

Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder

PR Newswire

a month ago

Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

StockStory

a month ago

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Insider Monkey

2 months ago

Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer

PR Newswire

2 months ago

Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer

Viatris Inc. (VTRS): Among the High-Dividend Stocks to Invest In Under $10

Insider Monkey

2 months ago

Viatris Inc. (VTRS): Among the High-Dividend Stocks to Invest In Under $10

3 Hated Stocks with Mounting Challenges

StockStory

2 months ago

3 Hated Stocks with Mounting Challenges

3 Beaten-Down Stocks That Are Trading Below Their Book Values

Motley Fool

2 months ago

3 Beaten-Down Stocks That Are Trading Below Their Book Values

Viatris to Pay $335 Million for Settlement of Opioid-Related Claims

Zacks

2 months ago

Viatris to Pay $335 Million for Settlement of Opioid-Related Claims

Viatris to Pay Up to $335 Million in Opioid Settlement

GuruFocus.com

2 months ago

Viatris to Pay Up to $335 Million in Opioid Settlement

MT Newswires

2 months ago

Viatris to Settle Opioid Claims Through Nationwide Framework

Viatris Statement on Nationwide Settlement to Resolve Opioid-Related Claims

PR Newswire

2 months ago

Viatris Statement on Nationwide Settlement to Resolve Opioid-Related Claims

Morningstar Research

2 months ago

Analyst Report: Viatris Inc.

Viatris Inc. (VTRS): Among the Oversold Stocks to Buy in 2025 Amid Inflation Fears

Insider Monkey

2 months ago

Viatris Inc. (VTRS): Among the Oversold Stocks to Buy in 2025 Amid Inflation Fears

Viatris to Report First Quarter 2025 Financial Results on May 8, 2025

PR Newswire

2 months ago

Viatris to Report First Quarter 2025 Financial Results on May 8, 2025

Is Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn?

Insider Monkey

2 months ago

Is Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn?

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

StockStory

2 months ago

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now?

Insider Monkey

2 months ago

Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now?

Argus Research

2 months ago

Analyst Report: Viatris Inc

Argus Research

2 months ago

Market Update: DKS, SLF, LYB, VTRS

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory

3 months ago

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

1 Healthcare Stock to Target This Week and 2 to Turn Down

StockStory

3 months ago

1 Healthcare Stock to Target This Week and 2 to Turn Down

Why Viatris Inc. (VTRS) Is Plunging So Far In 2025

Insider Monkey

3 months ago

Why Viatris Inc. (VTRS) Is Plunging So Far In 2025

MT Newswires

3 months ago

Jefferies Adjusts Viatris Price Target to $13 From $15, Maintains Buy Rating

Viatris to Present at the Barclays 27th Annual Global Healthcare Conference

PR Newswire

3 months ago

Viatris to Present at the Barclays 27th Annual Global Healthcare Conference

MT Newswires

3 months ago

Piper Sandler Adjusts Price Target on Viatris to $10 From $14, Maintains Neutral Rating

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory

3 months ago

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Is Viatris Inc. (VTRS) the Best Weight Loss Drug Stock to Buy According to Analysts?

Insider Monkey

3 months ago

Is Viatris Inc. (VTRS) the Best Weight Loss Drug Stock to Buy According to Analysts?

Here's What Key Metrics Tell Us About Viatris (VTRS) Q4 Earnings

Zacks

3 months ago

Here's What Key Metrics Tell Us About Viatris (VTRS) Q4 Earnings

MT Newswires

3 months ago

Barclays Adjusts Price Target on Viatris to $9 From $12, Keeps Underweight Rating

Why Viatris Inc. (VTRS) Went Down on Thursday

Insider Monkey

3 months ago

Why Viatris Inc. (VTRS) Went Down on Thursday

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Viatris Inc Earnings Call

GuruFocus.com

3 months ago

Viatris Inc (VTRS) Q4 2024 Earnings Call Highlights: Strong Cash Flow and Debt Reduction Amid ...

Morningstar Research

3 months ago

Analyst Report: Viatris Inc.

S&P 500 Gains and Losses Today: Nvidia Leads Chip, AI Stocks Lower

Investopedia

3 months ago

S&P 500 Gains and Losses Today: Nvidia Leads Chip, AI Stocks Lower

Why Viatris (VTRS) Shares Are Falling Today

StockStory

3 months ago

Why Viatris (VTRS) Shares Are Falling Today

Viatris Q4 Earnings and Revenues Miss Estimates, Stock Plunges

Zacks

3 months ago

Viatris Q4 Earnings and Revenues Miss Estimates, Stock Plunges

MT Newswires

3 months ago

Sector Update: Health Care Stocks Higher Thursday Afternoon

MT Newswires

3 months ago

Sector Update: Health Care

Is Viatris Inc. (VTRS) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey

3 months ago

Is Viatris Inc. (VTRS) the Best Low Price Pharma Stock to Invest In Right Now?

Viatris Shares Decline After Earnings Miss, Lower 2025 Guidance

GuruFocus.com

3 months ago

Viatris Shares Decline After Earnings Miss, Lower 2025 Guidance

Viatris (VTRS) Q4 Earnings and Revenues Lag Estimates

Zacks

3 months ago

Viatris (VTRS) Q4 Earnings and Revenues Lag Estimates

Viatris (NASDAQ:VTRS) Misses Q4 Revenue Estimates, Stock Drops

StockStory

3 months ago

Viatris (NASDAQ:VTRS) Misses Q4 Revenue Estimates, Stock Drops

MT Newswires

3 months ago

Viatris' Q4 Adjusted Earnings, Revenue Fall; Provides 2025 Guidance

Associated Press Finance

3 months ago

Viatris: Q4 Earnings Snapshot

Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance

PR Newswire

3 months ago

Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance

Viatris Earnings: What To Look For From VTRS

StockStory

3 months ago

Viatris Earnings: What To Look For From VTRS

What's in Store for These 5 Biotech Stocks This Earnings Season?

Zacks

3 months ago

What's in Store for These 5 Biotech Stocks This Earnings Season?

Stay Ahead of the Game With Viatris (VTRS) Q4 Earnings: Wall Street's Insights on Key Metrics

Zacks

3 months ago

Stay Ahead of the Game With Viatris (VTRS) Q4 Earnings: Wall Street's Insights on Key Metrics

What's in the Cards for Viatris Stock This Q4 Earnings?

Zacks

3 months ago

What's in the Cards for Viatris Stock This Q4 Earnings?

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

StockStory

3 months ago

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline

Zacks

3 months ago

Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline

Uniting Against AMR: Global Solutions Need Local and Global Collaboration

ACCESS Newswire

3 months ago

Uniting Against AMR: Global Solutions Need Local and Global Collaboration

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

StockStory

3 months ago

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

3 Reasons to Sell VTRS and 1 Stock to Buy Instead

StockStory

3 months ago

3 Reasons to Sell VTRS and 1 Stock to Buy Instead

50 Years of Service: From Milkman's Son to Advancing Access to Medicines

ACCESS Newswire

3 months ago

50 Years of Service: From Milkman's Son to Advancing Access to Medicines

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

StockStory

4 months ago

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

StockStory

4 months ago

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

PR Newswire

4 months ago

Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

MT Newswires

4 months ago

BofA Adjusts Price Target on Viatris to $11 From $12

Morningstar Research

4 months ago

Analyst Report: Viatris Inc.

Share on Social Networks: